Apyx Medical Corp. (APYX)
2.88
-0.17
(-5.57%)
USD |
NASDAQ |
Sep 10, 16:00
2.88
0.00 (0.00%)
After-Hours: 20:00
Apyx Medical Shareholders Equity (Quarterly) : 10.66M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.66M |
| March 31, 2026 | 12.83M |
| December 31, 2025 | 14.54M |
| September 30, 2025 | 5.848M |
| June 30, 2025 | 7.253M |
| March 31, 2025 | 10.51M |
| December 31, 2024 | 14.21M |
| September 30, 2024 | 11.04M |
| June 30, 2024 | 14.75M |
| March 31, 2024 | 20.25M |
| December 31, 2023 | 26.70M |
| September 30, 2023 | 33.35M |
| June 30, 2023 | 36.60M |
| March 31, 2023 | 36.05M |
| December 31, 2022 | 37.58M |
| September 30, 2022 | 41.99M |
| June 30, 2022 | 45.90M |
| March 31, 2022 | 49.56M |
| December 31, 2021 | 53.70M |
| September 30, 2021 | 54.35M |
| June 30, 2021 | 57.36M |
| March 31, 2021 | 60.04M |
| December 31, 2020 | 63.72M |
| September 30, 2020 | 64.20M |
| June 30, 2020 | 66.84M |
| Date | Value |
|---|---|
| March 31, 2020 | 70.43M |
| December 31, 2019 | 71.26M |
| September 30, 2019 | 76.73M |
| June 30, 2019 | 80.58M |
| March 31, 2019 | 84.01M |
| December 31, 2018 | 87.77M |
| September 30, 2018 | 90.60M |
| June 30, 2018 | 21.57M |
| March 31, 2018 | 21.47M |
| December 31, 2017 | 22.03M |
| September 30, 2017 | 22.52M |
| June 30, 2017 | 23.57M |
| March 31, 2017 | 24.70M |
| December 31, 2016 | 26.22M |
| September 30, 2016 | 20.63M |
| June 30, 2016 | 21.30M |
| March 31, 2016 | 21.64M |
| December 31, 2015 | 23.40M |
| September 30, 2015 | 24.62M |
| June 30, 2015 | 26.11M |
| March 31, 2015 | 26.19M |
| December 31, 2014 | 4.694M |
| September 30, 2014 | 9.765M |
| June 30, 2014 | 12.30M |
| March 31, 2014 | 11.80M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
| Baxter International, Inc. | 6.206B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 61.07M |
| Total Liabilities (Quarterly) | 49.98M |
| Debt to Equity Ratio | 3.717 |
| Current Ratio | 5.683 |
| Net Debt Paydown Yield | -0.08% |